Show Summary Details
Page of

Alterations of the Serotonin–Melatonin Pathway in Autism Spectrum Disorders: Biological Evidence and Clinical Consequences 

Alterations of the Serotonin–Melatonin Pathway in Autism Spectrum Disorders: Biological Evidence and Clinical Consequences
Chapter:
Alterations of the Serotonin–Melatonin Pathway in Autism Spectrum Disorders: Biological Evidence and Clinical Consequences
Author(s):

Cécile Pagan

, Richard Delorme

, Jean-Marie Launay

, and Thomas Bourgeron

DOI:
10.1093/med/9780199744312.003.0015
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 February 2020

This chapter discusses the mechanisms of the alterations of the serotonin–melatonin pathway associated with ASDs, their relevance to autistic symptoms, and their therapeutic implications.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.